Sophie van Rijn1,2. 1. Leiden University, Clinical Neurodevelopmental Sciences. 2. Leiden Institute for Brain and Cognition, Leiden, the Netherlands.
Abstract
PURPOSE OF REVIEW: About one in 650-1000 children is born with an extra X or Y chromosome, referred to as sex chromosome trisomies (SCTs). Studying SCTs may uncover unique insights in neurodevelopmental pathways underlying the risk for neurobehavioral problems and psychopathology. There is also a clinical need for more knowledge about the phenotype of SCT with the recent introduction of noninvasive prenatal screening. RECENT FINDINGS: The reviewed studies illustrate an increased vulnerability for psychopathology such as (symptoms of) autism spectrum disorder, attention-deficit/hyperactivity disorder, anxiety, depression and, to a lesser degree, psychotic disorders. Although traditionally the primary focus has been on language and learning problems, recent research suggests that impairments in executive functioning, social cognition and emotion regulation may also be key factors underlying the risk for neurobehavioral problems. SUMMARY: The research field of SCT is in need of a more longitudinal perspective to identify early markers of 'at risk' development, and to assess the effectiveness of early interventions. Neurocognitive markers that signal compromised neurodevelopment may prove to be helpful in this. Variability in the SCT phenotype provides a unique opportunity to identify not only genetic but also environmental factors that shape neurodevelopmental outcome, calling for studies focused on understanding individual differences.
PURPOSE OF REVIEW: About one in 650-1000 children is born with an extra X or Y chromosome, referred to as sex chromosome trisomies (SCTs). Studying SCTs may uncover unique insights in neurodevelopmental pathways underlying the risk for neurobehavioral problems and psychopathology. There is also a clinical need for more knowledge about the phenotype of SCT with the recent introduction of noninvasive prenatal screening. RECENT FINDINGS: The reviewed studies illustrate an increased vulnerability for psychopathology such as (symptoms of) autism spectrum disorder, attention-deficit/hyperactivity disorder, anxiety, depression and, to a lesser degree, psychotic disorders. Although traditionally the primary focus has been on language and learning problems, recent research suggests that impairments in executive functioning, social cognition and emotion regulation may also be key factors underlying the risk for neurobehavioral problems. SUMMARY: The research field of SCT is in need of a more longitudinal perspective to identify early markers of 'at risk' development, and to assess the effectiveness of early interventions. Neurocognitive markers that signal compromised neurodevelopment may prove to be helpful in this. Variability in the SCT phenotype provides a unique opportunity to identify not only genetic but also environmental factors that shape neurodevelopmental outcome, calling for studies focused on understanding individual differences.
Authors: Sophie van Rijn; André Aleman; Hanna Swaab; Tessel Krijn; Guy Vingerhoets; René Kahn Journal: J Int Neuropsychol Soc Date: 2007-11 Impact factor: 2.892
Authors: Judith L Ross; David P Roeltgen; Gerry Stefanatos; Rebecca Benecke; Martha P D Zeger; Harvey Kushner; Purita Ramos; Frederick F Elder; Andrew R Zinn Journal: Am J Med Genet A Date: 2008-03-15 Impact factor: 2.802
Authors: Kristiina Kompus; René Westerhausen; Lars-Göran Nilsson; Kenneth Hugdahl; Susan Jongstra; Alexander Berglund; Stefan Arver; Ivanka Savic Journal: Psychiatry Res Date: 2011-03-22 Impact factor: 3.222
Authors: Nancy Raitano Lee; Payal Anand; Elizabeth Will; Elizabeth I Adeyemi; Liv S Clasen; Jonathan D Blumenthal; Jay N Giedd; Lisa A Daunhauer; Deborah J Fidler; Jamie O Edgin Journal: Front Behav Neurosci Date: 2015-10-20 Impact factor: 3.558
Authors: Nicole Tartaglia; Susan Howell; Shanlee Davis; Karen Kowal; Tanea Tanda; Mariah Brown; Cristina Boada; Amanda Alston; Leah Crawford; Talia Thompson; Sophie van Rijn; Rebecca Wilson; Jennifer Janusz; Judith Ross Journal: Am J Med Genet C Semin Med Genet Date: 2020-06-07 Impact factor: 3.908
Authors: Junko Matsuzaki; Luke Bloy; Lisa Blaskey; Judith Miller; Emily S Kuschner; Matthew Ku; Marissa Dipiero; Megan Airey; J Christopher Edgar; David Embick; Judith L Ross; Timothy P L Roberts Journal: Dev Neurosci Date: 2019-07-05 Impact factor: 2.984
Authors: Nienke Bouw; Hanna Swaab; Nicole Tartaglia; Rebecca L Wilson; Kim Van der Velde; Sophie van Rijn Journal: Eur Child Adolesc Psychiatry Date: 2022-09-15 Impact factor: 5.349
Authors: Ethan T Whitman; Siyuan Liu; Erin Torres; Allysa Warling; Kathleen Wilson; Ajay Nadig; Cassidy McDermott; Liv S Clasen; Jonathan D Blumenthal; François M Lalonde; Stephen J Gotts; Alex Martin; Armin Raznahan Journal: Cereb Cortex Date: 2021-07-29 Impact factor: 5.357
Authors: Allysa Warling; Mani Yavi; Liv S Clasen; Jonathan D Blumenthal; François M Lalonde; Armin Raznahan; Siyuan Liu Journal: Cereb Cortex Date: 2021-10-22 Impact factor: 4.861
Authors: Allysa Warling; Siyuan Liu; Kathleen Wilson; Ethan Whitman; François M Lalonde; Liv S Clasen; Jonathan D Blumenthal; Armin Raznahan Journal: Am J Med Genet C Semin Med Genet Date: 2020-06-08 Impact factor: 3.359